Skip to main content
S&P 5007,650.50+0.17%DOW51,682.64-0.18%NASDAQ26,522.54+0.39%BTC$81,273.00+6.27%ETH$2,618.91+7.14%GOLD$4,415.90+0.37%OIL$95.47-1.81%
Smart Investors Daily
GT

OTC · GTHP

Guided Therapeutics, Inc.

Healthcare · Medical - Devices

$0.23

Down-$0.02 (-8.00%)

Updated Sep 20, 2026, 3:12 AM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
18.31M
P/E ratio
-6.69
Dividend yield
0.00%
52-week range
— – —
Volume
5K
Avg. volume
5.75K

Price performance

GTHP price history

1M range · 0 trading sessions · Daily adjusted prices

GTHP does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest GTHP news

The latest Smart Investors Daily articles mentioning GTHP.

Stock researchCompany · Overview

GTHP research

Overview

Company profile and research snapshot.

Company profile

GUIDED THERAPEUTCS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 9, 2026

Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer

PEACHTREE CORNERS, Ga., September 09, 2026--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that it has reached an agreement with the Ministry of Health to co-develop LuViva for primary screening of cervical cancer in Türkiye. The first step of the collaborative agreement is to conduct an 800 patient clinical study to optimize LuViva’s AI pattern recognition algorithms for real time detection of cellular changes that occur in the earliest stages

businesswire.com · Nov 19, 2025

Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had completed an initial supply agreement with Yuanshuo Medical Instruments Corporation (YMIC). YMIC is headquartered in Jiangsu province, China and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the agreement, YMIC will initially purchase $200,000 worth of LuViva devices and single-.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By